[Studies on the mechanism of action of sulfonylurea compounds. Effect of glibornuride and insulin on blood sugar, plasma catecholamines and on the immunologically determinable insulin following blockade of adrenergic receptors].
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001786:Blood Glucose; D001892:Camphanes / Q000008:administration & dosage / Q000494:pharmacology; D004285:Dogs; D004837:Epinephrine / Q000097:blood*; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D007275:Injections, Intravenous; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D009638:Norepinephrine / Q000097:blood; D010646:Phentolamine / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000187:drug effects; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D001892:Camphanes; D007004:Hypoglycemic Agents; D007328:Insulin; D011941:Receptors, Adrenergic; D013453:Sulfonylurea Compounds; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine
Untersuchungen zum Wirkungsmechanismus der Sulfonylharnstoffe. Der Einfluss von Glibormurid und Insulin auf den Blutzucker, die Plasma-Katecholamine und das immunologisch messbare Insulin nach Blockade adrenerger Rezeptoren.